As Technologies for Nucleotide Therapeutics Mature, Products Emerge

Authors

Keywords

oligonucleotide therapeutics, antisense, ribozyme, small interfering RNA, RNAi, miRNA, FDA approval, technology forecasting, data analytics, technology management

Journal

Molecular Therapy-Nucleic Acids

Volume 9, Issue -, Pages 379-386

Publisher

Elsevier BV

Online

2017-10-28

DOI

10.1016/j.omtn.2017.10.017

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started